Ka lāʻau "Vikasol": olelo

E hoomakaukau ai "Vikasol" (papa), ke aʻo hoʻomōakaaka komo 15 mg o menadione paʻakai bisulfite.

Medicine "Vikasol" i loko o ka palapala o ka pāʻoihana no intramuscular ka pahu kui kēlā me kēia ampoule he 10 mg o menadione paʻakai bisulfite.

Ka lāʻau e pili ana i ka lapaʻau a me ka mea lāʻau lapaʻau pūʻulu hemostatic konohiki. Mea lāʻau lapaʻau 'ana ua ma muli o ka mea i ka lāʻau "Vikasol" ua synthetically ho okumu i ka mea like o ka wikamina K, wailana i loko o ka wai. Ka mea, ua ālai 'i ke kahua o ka prothrombin. Pono ia ma luna o 'ona' ole i loko o ke koko coagulation, ho'ā 'ia i loko o ke ake; Ua kōkua e hoihoi koko clotting kaʻina.

I ka hana o ka menadione i loko o ke kino malama he umikumamalua hora ma hope hooponopono. Ka lāʻau "Vikasol" (papa) ua hemolele ke kemu ma ke kino. I hana i ke koko me ka wai koko nā polokina, i kēia kaʻina mea reversible. Nei lāʻau hoʻomāhuahua i loko o ke kino o ke ake, spleen, myocardium. Ma ka kekahi kahua o ka pūnao o menadione paʻakai bisulphite hana wikamina K2.

wikamina K decomposition huahana poe bisulfate, posapahate digdyukuronid-2-meto-1,4-naphthoquinone, mai ka 70% o ka residues loko mai o ka mimi.

Ka lāʻau "Vikasol": olelo ao no ka hoʻohana. hoike

Ka lāʻau 'Ua kuhikuhi:

• me ka hemorrhagic maʻi pale, pili me ka gipoprotrombinemiey;
• me ka deficiency o ka wikamina K (nā mea maʻi undergoing lapaʻau o jaundice, hepatitis, cirrhosis, hooloihiia diarrhea);
• haemorrhagic mai i loko o ke keiki;
• me ka nui o ke koko emi like me ka hopena o ka hewa, trauma aʻoki kino;
• me ka kaumaha uterine kahe ana ke koko ma ka gynecology;
• menorrhagia;
• no ka kahe ana ke koko mai ana ka lapaʻauʻia i loko o ka hui anticoagulants, me he mau 'hoa;
• Hāpai keiki ma ka III trimester o ka hāpai keiki, e pale kahe ana ke koko i loko o ke keiki;
• i makaukau no keʻoki kino, ma hopeʻoki kino;
• no ka kahe ana ke koko, kena ae la ia e gastric ulcer a duodenal ulcer;
• me ka nui a me ka gemorroidalnom epistaxis.

Ka lāʻau "Vikasol": aʻo ma o ka palapala noi. laʻau heluna

Kauka prescribes kanaka makua ku una mahele lāʻau menadione paʻakai bisulfite, mai ka 15 mg i 30 mg. V / m, i ka mahele lāʻau He 10 mg i 15 mg.

Children ma lalo o hoʻokahi makahiki o ka makahiki, i ka mahele lāʻau ua i hoakaka ia ma ka 2-5mg lāʻau.

Children ma lalo o ka makahiki o 2 makahiki, ua hoakaka ia 6 mg.

Children mai 4 makahiki 3y.o. e koho 8 mg.

Children mai ka 5 makahiki a hiki i 9 makahiki i hoakaka ia 10 mg.

Children elemakule 10 makahiki i ka 14 makahiki koho 15 mg.

Mau nā māhele "menadione" lawelawe 2-3 manawa i ka lā. Ka lōʻihi like 'ole o ka lapaau ke kauka nā pūʻulu pākahi.

Mai oi aku ka kela la i keia mahele lāʻau no nā mākua - 60 mg ku una, 30 mg intramuscularly. He mea hiki ole ke kau aku i hookahi mahele lāʻau no nā mākua, uaʻoi kona kiʻekiʻe ma mua o 30 mg ku una, 15 mg intramuscularly.

ʻO kā mākou allowable kela la i keia mahele lāʻau "Vikasol" ai 'no na kamalii uuku, he 4 mg.

Ka lāʻau "Vikasol": olelo ao no ka hoʻohana. ʻaoʻao waiwai

Ma lapaʻau e hookolokolo ai ia i Ua pohihihi allergic reactions i hoike mai ai ia ili poʻe noʻonoʻoʻole, pruritus, erythema, urticaria, bronchospasm.

Haunaele ma ka'ōnaehana o ke koko clotting kānāwai hemolytic mai o ke keiki.

Ka lāʻau "Vikasol": olelo ao no ka hoʻohana. Contraindications

He mea hiki ole ia i koi 'ia i kekahi lāʻau:

• ma ka kiʻekiʻe koko clotting;
• na symptoms o thromboembolism;
• hypersensitivity e menadione paʻakai bisulfite.

Hapai keiki o na wahine a me breastfeeding makuwahine, i ka lāʻau "Vikasol" koho i nāʻikepili.

Cautions

E hoomanawanui i ka poe i hookupaa kāna hana pili i ka outflow o bile, i ka lāʻau 'ua lawelawe parenterally. Ma ka iapaau ana o nā mea maʻi e loaa ana mai ka hemophilia a me ka maʻi Verlgofa, lapaʻau "Vikasol" 'aʻole e haawi maikaʻi hopena.

E ho ohana ana i ka lāʻau 'ka poʻe me ku una ha anticoagulants ho'ēmi i kā anticoagulant kanawai.